AI radiology advantage Quantitative Insights offers an FDA-cleared AI based computer-aided diagnosis system (QuantX) that improves radiologist accuracy and reduces missed cancers, presenting a compelling value proposition for hospitals and imaging centers seeking diagnostic precision and efficiency gains.

Cost and time savings The QuantX platform claims to significantly reduce costs and improve reading times for complex multi-modality cases, creating an opportunity to target budget-conscious radiology groups and large imaging facilities aiming to increase throughput.

Breast cancer focus With QuantX-specific breast cancer decision support tools (QI Score and Similar Case Database Compare), there is a clear entry point to partner with breast imaging centers, cancer institutes, and screening programs seeking enhanced breast lesion analysis and biopsy-pathway optimization.

Innovation roadmap A stated roadmap of deep learning and next-generation analytics suggests potential product expansion into other radiology domains, offering cross-sell and upsell opportunities to existing customers as the platform broadens applicability.

Strategic partnerships Leveraging technology licensed from a top research institution and recognizing industry recognition (iBIO iCON Innovator Award) can be used in outreach to academic medical centers, research hospitals, and early-adopter clinics seeking validated, prestigious AI solutions.